The results of a trial of another oral vaccine called Rotarix, developed by GlaxoSmithKline, showed it was effective against the most common strain of rotavirus and able to prevent 85% of severe cases.
BBC: NEWS | Health | Diarrhoea vaccine tests 'hopeful'